Infliximab therapy inpatients with ankylosing spondylitis: An open label study on efficacy and safety

被引：0
|
作者：
Macieira, C [1 ]
Costa, M [1 ]
Ramos, F [1 ]
Sequeira, G [1 ]
Castelao, W [1 ]
de Queiroz, MV [1 ]
机构：
[1] Hosp Santa Maria, Dept Rheumatol, Lisbon, Portugal
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2004年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：404 / 404
页数：1
相关论文
共 50 条
  • [41] Long term safety and efficacy of open-label infliximab for SLE
    Aringer, M.
    Houssiau, F.
    Graninger, W. B.
    Feier, E.
    Steiner, G.
    Smolen, J. S.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 455 - 455
  • [42] CLINICAL EFFICACY AND SAFETY OF INFLIXIMAB - FIRST RESULTS AFTER A DECADE OF CONTINUOUS TREATMENT IN ANKYLOSING SPONDYLITIS
    Baraliakos, X.
    Listing, J.
    Fritz, C.
    Haibel, H.
    Alten, R.
    Burmester, G.
    Krause, A.
    Schewe, S.
    Schneider, M.
    Soerensen, H.
    Schmidt, R.
    Sieper, J.
    Braun, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 252 - 252
  • [43] The efficacy and safety of infliximab used in patients with ankylosing spondylitis after unilateral total hip arthroplasty
    Wang, Jian
    Zhang, Yang
    Zhao, Liang
    Li, Zhi-han
    Shi, Zhan-jun
    HIP INTERNATIONAL, 2013, 23 (04) : 406 - 410
  • [44] A spinal pain score (SpiPS) performed by the rheumatologist in ankylosing spondylitis (AS): Evaluation of sensitivity to change in a multicenter open label study with infliximab
    Haibel, H
    Zinke, S
    Rudwaleit, M
    Sieper, J
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 401 - 401
  • [45] Observation of Clinical Efficacy of Etanercept and Infliximab in Patients with Ankylosing Spondylitis
    Zhang, Fengfei
    Sun, Qingzeng
    Qi, Yudong
    Shen, Yang
    Shi, Yingchun
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2020, 126 : 426 - 427
  • [46] Evaluation of the efficacy and safety of infliximab on psoriatic nails: an unblinded, nonrandomized, open-label study
    Rigopoulos, D.
    Gregoriou, S.
    Stratigos, A.
    Larios, G.
    Korfitis, C.
    Papaioannou, D.
    Antoniou, C.
    Ioannides, D.
    BRITISH JOURNAL OF DERMATOLOGY, 2008, 159 (02) : 453 - 456
  • [47] Results from an open-label extension study of etanercept in ankylosing spondylitis
    Davis, J
    Webb, A
    Lund, S
    Sack, K
    ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2004, 51 (02): : 302 - 304
  • [48] Infliximab: Additional safety data from an open label study
    Daniel, CL
    Moreland, LW
    JOURNAL OF RHEUMATOLOGY, 2002, 29 (04) : 647 - 649
  • [49] Efficacy and tolerance of infliximab in the treatment of ankylosing spondylitis (AS): 2-year open follow-up
    Gossec, L
    Le Henanff, A
    Vignon, E
    Claudepierre, P
    Devauchelle, V
    Wendling, D
    Lespessailles, E
    Euller-Ziegler, L
    Sibilia, J
    Perdriger, A
    Alexandre, C
    Breban, M
    Dougados, M
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 318 - 318
  • [50] A multicenter, open-label, long-term study of three-year infliximab administration in Japanese patients with ankylosing spondylitis
    Kobayashi, Shigeto
    Yoshinari, Toru
    MODERN RHEUMATOLOGY, 2017, 27 (01) : 142 - 149
12345